Skip to main content
Clinical Trials/JPRN-UMIN000025373
JPRN-UMIN000025373Completed未知

A study for the effects of ingestion of food in adults with higher oxidative stress level and lower antioxidant ability : A randomized, double-blind, placebo controlled trial - A study for the effects of ingestion of food in adults with higher oxidative stress level and lower antioxidant ability

TTC Co., Ltd.0 sites40 target enrollmentStarted: December 23, 2016Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
40years-old to 65years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1)Subjects who regularly visit to ophthalmologic hospital for serious eye disease (2)Subjects who answered that there was a history of strength myopia in questionnaire (3)Subjects who received ophthalmic surgery within 3 months (4)Subjects who have a disease affecting the study results (e.g., cancer, hypertension, diabetes, amblyopia, autoimmune disease, thyroid dysfunction) (5) Subjects who have been taking foods affecting the study results once a week or more in the past month or expected to use once a week or more during study (6) Subjects who may have allergy to the test foods (7) Subjects who have a disease requiring regular medication or a history of serious diseases for which medication was required (8) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (9) Subjects who have participated in other clinical study within the last one month prior to the current study (10) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating (11) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (12) Subjects who are judged as unsuitable by doctor for other reasons

Investigators

Sponsor
TTC Co., Ltd.

Similar Trials